Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-382463

Chief Financial Officer acquired 276 shares (grant or award)

  • Chief Financial Officer gave up 102 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Mokari Atabak · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-01 Grant or award : show line 1 in the form +138 $113.38 $15,646 16,268 D
2026-09-01 Grant or award : show line 2 in the form +138 16,406 D
2026-09-02 Shares withheld for taxes : show line 3 in the form −102 $113.38 $11,565 16,304 D
Loading xslF345X06/ownership.xml…